GSK and Regeneron to mine gene data from 500000 Britons
Mar 23, 2017, 16:33 PM
by
Michael Croft
Reuters | Britain's GlaxoSmithKline and U.S.-based Regeneron Pharmaceuticals are embarking on a joint project with UK Biobank, the world's most detailed biomedical database, to hunt for new clues linking genes and disease.
March 23, 2017 | Britain's GlaxoSmithKline and U.S.-based Regeneron Pharmaceuticals are embarking on a joint project with UK Biobank, the world's most detailed biomedical database, to hunt for new clues linking genes and disease. Reuters